272 related articles for article (PubMed ID: 23623990)
21. Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson's disease.
Ismael S; Colvin RA; Lee D
Brain Res; 2024 Jan; 1822():148641. PubMed ID: 37866407
[TBL] [Abstract][Full Text] [Related]
22. Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity.
Madiha S; Batool Z; Tabassum S; Liaquat L; Sadir S; Shahzad S; Naqvi F; Saleem S; Yousuf S; Nawaz A; Ahmad S; Sajid I; Afzal A; Haider S
PLoS One; 2021; 16(11):e0258928. PubMed ID: 34767546
[TBL] [Abstract][Full Text] [Related]
23. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
24. Lowered iPLA
Chao H; Liu Y; Fu X; Xu X; Bao Z; Lin C; Li Z; Liu Y; Wang X; You Y; Liu N; Ji J
Exp Neurol; 2018 Feb; 300():74-86. PubMed ID: 29104115
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
[TBL] [Abstract][Full Text] [Related]
26. Ameliorative effects of flavonoids and polyketides on the rotenone induced Drosophila model of Parkinson's disease.
Siima AA; Stephano F; Munissi JJE; Nyandoro SS
Neurotoxicology; 2020 Dec; 81():209-215. PubMed ID: 32937168
[TBL] [Abstract][Full Text] [Related]
27. Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats.
El-Saiy KA; Sayed RH; El-Sahar AE; Kandil EA
Chem Biol Interact; 2022 Feb; 354():109841. PubMed ID: 35104487
[TBL] [Abstract][Full Text] [Related]
28. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
Sonia Angeline M; Sarkar A; Anand K; Ambasta RK; Kumar P
Neuroscience; 2013 Dec; 254():379-94. PubMed ID: 24070629
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.
Darbinyan LV; Hambardzumyan LE; Simonyan KV; Chavushyan VA; Manukyan LP; Badalyan SA; Khalaji N; Sarkisian VH
Metab Brain Dis; 2017 Dec; 32(6):1791-1803. PubMed ID: 28695411
[TBL] [Abstract][Full Text] [Related]
30. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.
Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA
J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
Abdelsalam RM; Safar MM
J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
[TBL] [Abstract][Full Text] [Related]
34. Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson's disease.
Liu LF; Song JX; Lu JH; Huang YY; Zeng Y; Chen LL; Durairajan SS; Han QB; Li M
Sci Rep; 2015 Nov; 5():16862. PubMed ID: 26578166
[TBL] [Abstract][Full Text] [Related]
35. Methods to characterize spontaneous and startle-induced locomotion in a rotenone-induced Parkinson's disease model of Drosophila.
Liao J; Morin LW; Ahmad ST
J Vis Exp; 2014 Aug; (90):. PubMed ID: 25178101
[TBL] [Abstract][Full Text] [Related]
36. Chronic exposure to rotenone, a dopaminergic toxin, results in peripheral neuropathy associated with dopaminergic damage.
Binienda ZK; Sarkar S; Mohammed-Saeed L; Gough B; Beaudoin MA; Ali SF; Paule MG; Imam SZ
Neurosci Lett; 2013 Apr; 541():233-7. PubMed ID: 23499956
[TBL] [Abstract][Full Text] [Related]
37. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
[TBL] [Abstract][Full Text] [Related]
38. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
Schmidt WJ; Alam M
J Neural Transm Suppl; 2006; (70):273-6. PubMed ID: 17017541
[TBL] [Abstract][Full Text] [Related]
39. Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method.
Madiha S; Tabassum S; Batool Z; Liaquat L; Sadir S; Shahzad S; Perveen T; Haider S
Pak J Pharm Sci; 2017 May; 30(3(Suppl.)):943-948. PubMed ID: 28655689
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.
Kakoty V; K C S; Dubey SK; Yang CH; Taliyan R
ACS Chem Neurosci; 2021 Jul; 12(14):2643-2660. PubMed ID: 34197084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
